March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Learn about substance abuse, dependence, and addiction, how they affect living with HIV, how to know if you have a problem, and what to do.
Get basic information about a variety of approaches to treating the metabolic changes that may result from HIV disease or HIV drugs.